Pomp,

Ooops. I think I used the wrong date. I think I incorrectly penciled in the original date of the 2016 AGM (September 12), which was cancelled. The date on the enrollment should have been August 29, 2016 at which time they stated in a news release that "The trial has already attained one quarter enrollment of the planned 2,400 patients and remains on track with internal projections." I'm assuming 600 patients due to the simple math involved. 

BearDownAZ

BTW, you never did follow up with any evidence of apabetalone affecting mitochondrial remodeling and the electron transport chain........